Valuation: NEW RAYNPV

Market Cap 45.14M 5.76M 4.93M 4.61M 4.22M 7.93M 551M 8.03M 54.52M 21.26M 277M 21.62M 21.15M 915M P/E 2024
-2.43x
P/E 2025 -2.3x
Enterprise Value 10.18M 1.3M 1.11M 1.04M 953K 1.79M 124M 1.81M 12.3M 4.8M 62.43M 4.88M 4.77M 206M EV / Sales 2024
0.15x
EV / Sales 2025 0.16x
Free-Float
64.72%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 48 31/07/2020
Corporate Secretary - 11/07/2023
Director TitleAgeSince
Director/Board Member 76 26/09/2013
Director/Board Member 50 20/06/2017
Chairman 48 15/05/2021
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+2.38% - - 5.76M
+1.63%-2.13%-40.02%-6.39% 15.73B
0.00%+0.46%-40.83%-23.83% 6.72B
+0.49%+2.25%-18.13%-12.75% 6.36B
-0.83%-0.42%-2.29%-23.01% 4.32B
+0.65%-1.99%-18.04%-38.82% 3.24B
-2.91%-1.40%+2.26%-36.86% 2.99B
+2.09%-0.75%-45.36%-24.10% 3.05B
-1.97%-3.96%-15.32%-7.12% 2.55B
+1.20%-1.30%+44.28% - 2.4B
Average +0.03%-0.87%-14.83%-21.61% 5.26B
Weighted average by Cap. +0.48%-0.84%-24.32%-17.10%

Financials

2024 2025
Net sales 93.94M 11.98M 10.26M 9.6M 8.79M 16.5M 1.15B 16.72M 113M 44.25M 576M 44.99M 44.01M 1.9B 130M 16.63M 14.24M 13.33M 12.2M 22.9M 1.59B 23.2M 157M 61.41M 799M 62.44M 61.08M 2.64B
Net income -31.01M -3.96M -3.39M -3.17M -2.9M -5.45M -378M -5.52M -37.46M -14.61M -190M -14.85M -14.53M -629M -20.07M -2.56M -2.19M -2.05M -1.88M -3.52M -245M -3.57M -24.24M -9.45M -123M -9.61M -9.4M -407M
Net Debt -60.71M -7.74M -6.63M -6.21M -5.68M -10.66M -741M -10.8M -73.32M -28.59M -372M -29.07M -28.44M -1.23B -34.96M -4.46M -3.82M -3.57M -3.27M -6.14M -427M -6.22M -42.22M -16.46M -214M -16.74M -16.38M -709M
Logo NEW RAYNPV
New Ray Medicine International Holding Ltd is an investment holding company principally engaged in the distribution and trading of pharmaceutical and the provision of marketing and promotion services. The Company operates its businesses through two segments. The Distribution and Trading of Pharmaceutical and Related Products segment is mainly engaged in the distribution and trading of drugs and chemical reagents for pharmaceutical. The Provision of Marketing and Promotion Services segment is mainly engaged in the provision of marketing and promotion services of drugs and chemical reagents for pharmaceutical. The Company mainly operates its businesses in the domestic market.
Employees
-